| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-01-16 18:10 Tx date 2026-01-16 |
$ONCO
Onco-Innovations Limited |
Heinzl, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,410
-5,700 vol $1.30 each |
210,000 | |
| Filed 2026-01-14 12:29 Tx date 2026-01-13 |
$ONCO
Onco-Innovations Limited |
Heinzl, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,380
-2,600 vol $1.30 each |
215,700 | |
| Filed 2026-01-09 11:17 Tx date 2026-01-08 |
$ONCO
Onco-Innovations Limited |
Heinzl, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+10,000 vol |
218,300 | |
| Filed 2026-01-09 11:16 Tx date 2026-01-08 |
$ONCO
Onco-Innovations Limited |
Heinzl, Richard
4 - Director of Issuer
Direct Ownership
|
Rights
36 - Conversion or exchange
|
-10,000 vol |
30,000 | |
| Filed 2025-11-26 19:04 Tx date 2025-11-26 |
$ONCO
Onco-Innovations Limited |
Heinzl, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+7,500 vol |
208,300 | |
| Filed 2025-11-26 19:03 Tx date 2025-11-26 |
$ONCO
Onco-Innovations Limited |
Heinzl, Richard
4 - Director of Issuer
Direct Ownership
|
Rights
36 - Conversion or exchange
|
-7,500 vol |
40,000 | |
| Filed 2025-11-07 17:52 Tx date 2025-11-05 |
$ONCO
Onco-Innovations Limited |
Heinzl, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-20,475
-11,700 vol $1.75 each |
200,800 | |
| Filed 2025-09-08 20:39 Tx date 2025-09-08 |
$ONCO
Onco-Innovations Limited |
Heinzl, Richard
4 - Director of Issuer
Direct Ownership
|
Rights
56 - Grant of rights
|
+10,000 vol |
47,500 | |
| Filed 2025-05-26 17:47 Tx date 2025-05-26 |
$ONCO
Onco-Innovations Limited |
Heinzl, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+7,500 vol |
212,500 | |
| Filed 2025-05-26 17:46 Tx date 2025-05-26 |
$ONCO
Onco-Innovations Limited |
Heinzl, Richard
4 - Director of Issuer
Direct Ownership
|
Rights
36 - Conversion or exchange
|
-7,500 vol |
37,500 | |
| Filed 2025-05-09 12:48 Tx date 2025-05-09 |
$ONCO
Onco-Innovations Limited |
Heinzl, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+200,000 vol |
205,000 | |
| Filed 2025-05-09 12:47 Tx date 2025-05-09 |
$ONCO
Onco-Innovations Limited |
Heinzl, Richard
4 - Director of Issuer
Direct Ownership
|
Rights
36 - Conversion or exchange
|
-200,000 vol |
45,000 | |
| Filed 2025-04-15 12:00 Tx date 2025-04-12 |
$ASEP
ASEP Medical Holdings Inc. |
Heinzl, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$96,000
+1,920,000 vol $0.05 each |
2,320,000 | |
| Filed 2025-03-27 13:29 Tx date 2025-03-26 |
$ONCO
Onco-Innovations Limited |
Heinzl, Richard
4 - Director of Issuer
Direct Ownership
|
Rights
36 - Conversion or exchange
|
-7,500 vol |
||
| Filed 2025-03-27 13:28 Tx date 2025-03-26 |
$ONCO
Onco-Innovations Limited |
Heinzl, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+7,500 vol |
||
| Filed 2025-03-26 19:45 Tx date 2025-03-26 |
$ONCO
Onco-Innovations Limited |
Heinzl, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+7,500 vol |
||
| Filed 2025-03-26 19:44 Tx date 2025-03-26 |
$ONCO
Onco-Innovations Limited |
Heinzl, Richard
4 - Director of Issuer
Direct Ownership
|
Rights
36 - Conversion or exchange
|
-7,500 vol |
||
| Filed 2025-03-26 19:45 Tx date 2025-03-26 |
$ONCO
Onco-Innovations Limited |
Heinzl, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+7,500 vol |
12,500 | |
| Filed 2025-03-26 19:44 Tx date 2025-03-26 |
$ONCO
Onco-Innovations Limited |
Heinzl, Richard
4 - Director of Issuer
Direct Ownership
|
Rights
36 - Conversion or exchange
|
-7,500 vol |
237,500 | |
| Filed 2024-03-14 14:44 Tx date 2024-03-12 |
$ASEP
ASEP Medical Holdings Inc. |
Heinzl, Richard
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-100,000 vol |
0 |